Abstract
Over the past 50 years, cancer research has significantly improved, starting with identifying the initial oncogene, a gene responsible for promoting cancer development. Cancer frequently involves disrupting molecular signaling pathways that govern cellular growth and differentiation. The P53 signaling pathway performs a fundamental function in the cellular stress response and is responsible for controlling the cell cycle, DNA repair, and apoptosis. The fault of this pathway has been associated with various types of cancer, making it a principal field of research in the study of molecular biology and the medicine of cancer therapy. The goal of this research is to thoroughly and precisely review and study the general P53 signaling pathway and its associated genes, including TP53, MDM2, MDM4, CDKN2A, CDKN2B, and TP53BP1. Obtaining information concerning the mechanisms and functions of these genes in the general P53 biopathway can provide valuable knowledge of the important progressions of cancer and the advance of new treatment approaches. Herein, we provide an up-to-date review of general P53 signaling pathway-related genes in cancer to better understand the molecular complexity underlying cancer research.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Basic Science in Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
